GBP treatment is neuroprotective in models of cortical deafferenation (Li et al., 2012), neonatal ischemia (Traa et al., 2008), and ischemic brain injury (Williams et al., 2006), likely due to attenuation of TSP/α2δ-1 signaling. The gene discussed is THBS1; the disease is ischemia.